Bayer Pharmaceuticals India – Gurgaon Office

Bayer Pharmaceuticals (India) Private Limited operates its India pharmaceutical division from Gurgaon, Haryana. Part of the German multinational life sciences company Bayer AG, the India division focuses on prescription medicines across oncology, haematology, women’s health, and cardiovascular disease, as well as consumer health products.

Products & Therapeutic Focus

Bayer India’s pharmaceutical portfolio includes Xarelto (rivaroxaban), Eylea (aflibercept), Stivarga (regorafenib), Nexavar (sorafenib), and Gadovist. The Consumer Health division markets products including Aspirin, Canesten, Bepanthen, and Aleve. Bayer’s Crop Science division also operates from the Gurgaon headquarters.

India Operations

The Gurgaon office coordinates regulatory affairs, medical affairs, pharmacovigilance, market access, and commercial operations for Bayer’s pharmaceutical business in India. Bayer India has been present in India for over a century and has a long history of contributing to Indian healthcare.

Contact Information

Company: Bayer Pharmaceuticals (India) Pvt. Ltd.
Location: Gurgaon (Gurugram), Haryana
Business Type: Global Pharmaceutical Subsidiary – Oncology, Cardiology & Consumer Health